This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

NICE guidance - cardiovascular risk estimation in type 1 and type 2 diabetes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Primary prevention for people with type 1 diabetes

  • statin treatment should be considered for the primary prevention of CVD in all adults with type 1 diabetes

  • statin treatment should be offered for the primary prevention of CVD to adults with type 1 diabetes who:
    • are older than 40 years or
    • have had diabetes for more than 10 years or
    • have established nephropathy or
    • have other CVD risk factors

  • start treatment for adults with type 1 diabetes with atorvastatin 20 mg

Primary prevention for people with type 2 diabetes

  • offer atorvastatin 20 mg for the primary prevention of CVD to people with type 2 diabetes who have a 10% or greater 10-year risk of developing CVD.
  • estimate the level of risk using the QRISK2 assessment tool

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.